Skip to content
← Holders

Boxer Capital Management, LLC

What Boxer Capital Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 2018299 · Filed Nov 16, 2026

Positions
47
Reported value
$1.2B
Opened
12
Closed
28
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Mar 31, 2025$332.5M
    28 positions
  2. Jun 30, 2025$198.7M
    20 positions
  3. Sep 30, 2025$313.7M
    34 positions
  4. Dec 31, 2025$456.9M
    45 positions
  5. Mar 31, 2026$761.7M
    54 positions
  6. Jun 30, 2026$1.3B
    63 positions
  7. Sep 30, 2026$1.2B
    47 positions
SecuritySharesChangeValueOf portfolio
TNGXTango Therapeutics, Inc.
10.5M−3.2%$262.6M22.8%
KODKodiak Sciences Inc.
1.5M±0%$140.1M12.2%
RVMDRevolution Medicines, Inc.
500K±0%$102.6M8.9%
KYMRKymera Therapeutics, Inc.
524.6K+22.2%$58.6M5.1%
REPLReplimune Group, Inc.
4.3M+7.4%$56.6M4.9%
ABVXAbivax S.A.
475K−21.5%$47M4.1%
SRZNSurrozen, Inc.
1.4M+23.1%$43.8M3.8%
CORTCorcept Therapeutics Inc
335.5K±0%$38.7M3.4%
PGENPrecigen, Inc.
4.3M−16.1%$37M3.2%
QUREuniQure N.V.
1.4M−5.3%$34.4M3%
DFTXDefinium Therapeutics, Inc.
683.6K−31.5%$26M2.3%
AMLXAmylyx Pharmaceuticals, Inc.
893.2K+11.6%$26M2.3%
SYRESpyre Therapeutics, Inc.
283.1K+183.1%$25.2M2.2%
PTGXProtagonist Therapeutics, Inc
170K±0%$24M2.1%
CELCCelcuity Inc.
286.2K−31.3%$22.8M2%
IRDOpus Genetics, Inc.
4.5M+61.1%$21.9M1.9%
QTTBQ32 Bio Inc.
2.6M−18.2%$21.3M1.9%
URGNUroGen Pharma Ltd.
500K±0%$20.3M1.8%
ACHVAchieve Life Sciences, Inc.
2.2MNew$17.4M1.5%
CCCCC4 Therapeutics, Inc.
4.2MNew$13.8M1.2%
TRAXFirst Tracks Biotherapeutics, Inc.
240KNew$8.5M0.7%
STTKShattuck Labs, Inc.
1.2M+17.5%$8M0.7%
SABSSAB Biotherapeutics, Inc.
2.5MNew$7.9M0.7%
CGEMCullinan Therapeutics, Inc.
450KNew$6.9M0.6%
CTNMContineum Therapeutics, Inc.
494K±0%$6.6M0.6%
CYTKCytokinetics Inc
100K±0%$6.6M0.6%
PALIPalisade Bio, Inc.
4.8M±0%$6.5M0.6%
CAPRCapricor Therapeutics, Inc.
642.8K−53.9%$6.1M0.5%
ETRAElectra Therapeutics, Inc.
450KNew$5.1M0.4%
ANTXAN2 Therapeutics, Inc.
944K+26.0%$5M0.4%
MAZEMaze Therapeutics, Inc.
175.5KNew$4.8M0.4%
EDSAEdesa Biotech, Inc.
937.4K+357.3%$3.9M0.3%
RLAYRelay Therapeutics, Inc.
200K−55.6%$3.6M0.3%
KZIAKazia Therapeutics Ltd
371.5K−33.7%$3.6M0.3%
ATTOAttovia Therapeutics, Inc.
200KNew$3.4M0.3%
PMVPPMV Pharmaceuticals, Inc.
2.1MNew$3.4M0.3%
CRESCENT BIOPHARMA INC.COM
226.8K−50.0%$3.3M0.3%
ZNTLZentalis Pharmaceuticals, Inc.
1MNew$2.8M0.2%
SRPTSarepta Therapeutics, Inc.
150K±0%$2.7M0.2%
ALLOAllogene Therapeutics, Inc.
1.5M±0%$2.4M0.2%
NRIXNurix Therapeutics, Inc.
100K±0%$2.4M0.2%
SIONSionna Therapeutics, Inc.
391.7KNew$2.1M0.2%
CLNNClene Inc.
477.5K±0%$1.9M0.2%
ACRSAclaris Therapeutics, Inc.
300KNew$1.6M0.1%
MISTMilestone Pharmaceuticals Inc.
666.7K±0%$577.1K0.1%
NMRANeumora Therapeutics, Inc.
954.1K−52.3%$568.8K0.1%
KPTIKaryopharm Therapeutics Inc.
127.5K−57.8%$155.6K0.1%